Enveric Biosciences ENVB
NASDAQ ENVB
$1.48 +0.02 (+1.37%)
At close: Oct 2, 2026 · 4:00 PM EDT

Enveric Biosciences (ENVB) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Enveric Biosciences (ENVB) reported Return on Capital Employed [ROCE] of -137.00% for Q2 2026, up 199.43 percentage points from -336.43% a year earlier and up 32.56 percentage points from the prior quarter.

Analysis

Enveric Biosciences (ENVB) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2025, Enveric Biosciences posted Return on Capital Employed [ROCE] of -276.72%, up 160.82 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a five-year change of +118.42 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -437.54% in FY2024 (-265.90 pp), -171.64% in FY2023 (-28.41 pp), -143.23% in FY2022 (+366.78 pp) and -510.02% in FY2021 (-114.88 pp).
  • The Q2 2026 figure ranks as the highest quarterly Return on Capital Employed [ROCE] since Q4 2022.
  • Year over year, Return on Capital Employed [ROCE] has now increased in each of the last three quarters, with an average year-over-year change of +101.15 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q3 2024 (a gain of 460.72 percentage points); the low point was Q3 2023 (a drop of 409.81 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -169.56% (Q1 2026), -230.26% (Q4 2025) and -319.88% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 17.83%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 17.92%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 6.28%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 19.32%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.54%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 16.66%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -5.97%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 11.86%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 20.76%
10 Enveric Biosciences 5.86 Mn -15.78 Mn - -137.00%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -137.00%
Mar 31, 2026 -169.56%
Dec 31, 2025 -230.26%
Sep 30, 2025 -319.88%
Jun 30, 2025 -336.43%
Mar 31, 2025 -321.28%
Dec 31, 2024 -393.69%
Sep 30, 2024 -193.00%
Jun 30, 2024 -150.00%
Mar 31, 2024 -334.34%
Dec 31, 2023 -527.87%
Sep 30, 2023 -653.72%
Jun 30, 2023 -361.08%
Mar 31, 2023 -207.17%
Dec 31, 2022 -129.27%
Sep 30, 2022 -243.91%
Jun 30, 2022 -228.15%
Mar 31, 2022 -229.04%
Dec 31, 2021 -142.03%
Sep 30, 2021 -38.53%
API Access

Enveric Biosciences Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ENVB&period=max&api_key=YOUR_API_KEY